Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Naples
Clinical trial register · Italy

Clinical Trials in Naples, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca79 Hoffmann-La Roche48 Merck Sharp & Dohme LLC40 Bristol-Myers Squibb37 National Cancer Institute, Naples36
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Naples

983 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Bologna, Forlì, Florence, Rome, Messina, Naples, Padova, Pisa
2027-11-23
Not yet open
Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass Surgery
NCT07622992Obesity (BMI > 35) and Diabetes Mellitus, Obesity (BMI > 35) and Dyslipemia, Obesity (BMI > 35) and High Blood Pressure
Mario Musella MD
Observational
96
Naples
2027-01-01
Not yet open
European Group for Research In Schizophrenia
Phase 3
171
Naples, Torino
2027-01-01
Not yet open
Stratification and Treatment in Early Psychosis Study -ASSIST
NCT07326124Treatment Resistant Psychosis, Psychosis
University of Oxford
Phase 3
250
Naples
2027-01
Not yet open
Stratification and Treatment in Early Psychosis Study - PROMOTE
NCT07434973Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis, Clinical High Risk for Developing Psychosis
DrugCannabidiol
University of Oxford
Phase 3
586
Bari, Naples, Pavia, Roma
2026-12-01
Not yet open
Chiesi Farmaceutici S.p.A.
Phase 3
700
Brescia, Brindisi, Genoa, Messina, Milan, Naples, Parma, Pisa
2026-11-16
Not yet open
Tracheostomy Practice in Adult Intensive Care Units
NCT07769021Tracheostomy Patients, Tracheostomy Decannulation, Intensive Care (ICU)
Royal College of Surgeons, Ireland
Observational
2,500
Genova, Naples, Torino
2026-11-02
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Chieti, Bari, Castellana Grotte (BA), Catanzaro, Cosenza, Naples, Salerno, Ferrara
2026-10-26
Not yet open
Medtronic MiniMed, Inc.
Not applicable
230
Bologna, Milan, Naples, Roma
2026-10-15
Not yet open
Novo Nordisk A/S
Phase 3
84
Naples, Florence, Milan, Padova
2026-10-09
Recruiting
Stratification and Treatment in Early Psychosis Study - ENHANCE
NCT06778564Psychosis, First Episode Psychosis, Psychotic Disorders, Psychotic Episode
University of Oxford
Phase 3
250
Naples
2026-10-05
Not yet open
Assembly Biosciences
Phase 2
80
Milan, Naples
2026-10
Not yet open
Colchicine Effect on Amyotrophic Lateral Sclerosis Patients
NCT07813858Amyotrophic Lateral Sclerosis
DrugColchicine
Azienda Ospedaliero-Universitaria di Modena
Phase 2
87
Milan, Modena, Naples, Novara, Pavia
2026-10
Not yet open
Daiichi Sankyo
Phase 3
103
Milan, Naples, Negrar
2026-09-30
Not yet open
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
NCT07808151Colon Cancer, Microsatellite Stable (MSS) Colon Cancer, Proficient Mismatch Repair (pMMR) Colon Cancer
DrugsPorustobart·Keytruda·Pembrolizumab
Solstice Oncology, Inc.
Phase 2
100
Milan, Naples, Pisa
2026-09-30
Not yet open
Probiotics for Sustained Health
NCT07835100Upper Respiratory Tract Infection (URTI)
BioGaia AB
Not applicable
70
Naples, Pisa
2026-09-25
Recruiting
Vividion Therapeutics, Inc.
Phase 2
140
Milan, Naples, Roma, Rozzano
2026-09-11
Recruiting
AstraZeneca
Phase 3
2,800
Bari, Bologna, Cosenza, Cremona, Genoa, Milan, Modena, Naples
2026-09-01
Recruiting
L19IL2/TNF in Patients With Basal Cell Carcinoma
NCT07227870Locally Advanced Basal Cell Carcinoma
DrugDaromun
Philogen S.p.A.
Phase 2
92
Naples, Roma, Rozzano, Siena
2026-09
Not yet open
Spinery Basivertebral Nerve Ablation for Vertebrogenic Chronic Low Back Pain
NCT07696507Low Back Pain, Chronic Low Back Pain (CLBP)
Axon srl
Not applicable
69
Cagliari, Cosenza, Naples
2026-09
Recruiting
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
NCT07228442Locally Advanced Cutaneous Squamous Cell Carcinoma
DrugDaromun
Philogen S.p.A.
Phase 2
92
Naples, Roma, Rozzano, Siena
2026-09
Not yet open
Eli Lilly and Company
Phase 3
170
Ancona, Florence, Genova, Messina, Milan, Naples, Verona
2026-09
Not yet open
Azienda USL Reggio Emilia - IRCCS
Observational
210
Bari, Bologna, Ferrara, Meldola, Milan, Modena, Naples, Reggio Emilia
2026-08-30
Recruiting
Novo Nordisk A/S
Phase 3
1,778
Chieti, Catanzaro, Naples, Ravenna, Chiavari, Milan, Roma, Lucca
2026-08-24
Recruiting
Boehringer Ingelheim
Phase 3
448
Ancona, Bari, Florence, Milan, Modena, Naples, Roma
2026-07-27
Recruiting
Bristol-Myers Squibb
Phase 2
260
Siena, Bergamo, Milan, Naples, Perugia
2026-07-27
Recruiting
UCB BIOSCIENCES, Inc.
Phase 3
200
Genova, Milan, Naples, Pisa, Troina
2026-07-14
Recruiting
Boehringer Ingelheim
Phase 3
390
Bari, Florence, Milan, Naples, Palermo, Roma, Verona
2026-07-10
Recruiting
Ipsen
Observational
30
Florence, Naples, Padova, Roma, Torino, Udine
2026-07-10
Not yet open
ROELMI HPC
Not applicable
80
Naples
2026-07-09
Recruiting
AstraZeneca
Phase 3
1,200
Bari, Bologna, Chieti, Milan, Modena, Naples, Roma
2026-07-06
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 3
400
Naples, Verona
2026-07-02
Not yet open
Pasquale Arpaia
Not applicable
40
Naples
2026-07-01
Recruiting
Prilenia
Phase 3
400
Bologna, Milan, Naples, Padova, Roma, San Giovanni Rotondo
2026-07-01
Not yet open
Functional Milk Supplementation to Reduce In-Stent Restenosis in STEMI Patients (SMASOEA Trial)
NCT07176104ST-elevation Myocardial Infarction (STEMI), In-stent Restenosis
Raffaele Marfella
Not applicable
140
Naples
2026-07
Not yet open
Neurolyser XR for the Treatment of Sacroiliitis
NCT07647757Sacroiliitis, Low Back Pain
Federico II University
Not applicable
30
Naples
2026-07
Recruiting
Chiesi Italia
Observational
75
Arezzo, Bari, Bologna, Caserta, Monza, Naples, Palermo
2026-06-15
Recruiting
AstraZeneca
Phase 3
150
Aviano, Bergamo, Genova, Milan, Naples
2026-06-15
Recruiting
Mechanical Insufflation-Exsufflation in Critically Ill Patients
NCT07420946Airway Clearance, Mechanical Insufflation-exsufflation, Mechanical Insufflation-exsufflation Session ( With Cough Assist), Delphi Study
Medipol University
Observational
30
Naples
2026-06-10
Recruiting
Bayer
Phase 3
117
Bergamo, Bologna, Genova, Milan, Naples, Padova, Roma, Torino
2026-06-01
Not yet open
Safety of Bronchoscopy in Patients With Interstitial Lung Disease
NCT07627594Interstitial Lung Disease (ILD), Bronchoscopy, Bronchoalveolar Lavage (BAL), Acute Exacerbation
University of Milan
Observational
427
Milan, Bologna, Genova, Legnano, Modena, Monza, Naples, Siena
2026-06-01
Recruiting
Philogen S.p.A.
Phase 2
180
Naples, Roma, Rozzano, Siena
2026-06-01
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
NCT07101328Lymphoma, Non-Hodgkin, B-cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular
Eli Lilly and Company
Phase 1
215
Bologna, Naples, Rozzano
2026-05-28
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Naples, Meldola, Parma, Aviano, Rome, Bergamo, Brescia, Milan
2026-05-21
Recruiting
Takeda
Phase 3
300
Florence, Rozzano, Pavia, Roma, Candiolo, Bologna, Milan, Naples
2026-05-21
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Chieti, Cosenza, Naples, Bentivoglio, Bologna, Ferrara, Reggio Emilia, Udine
2026-05-11
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
San Giovanni Rotondo, Naples, Pisa
2026-05-06
Not yet open
ISTITUTO FARMOCHIMICO FITOTERAPICO: EPO SRL
Not applicable
99
Naples
2026-05-05
By invitation
Federico II University
Not applicable
20
Naples
2026-05-04
Not yet open
National Cancer Institute, Naples
Phase 2
48
Naples
2026-05
Recruiting
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
52
Caserta, Catania, Cinisello Balsamo, Florence, Naples, Padova, Palermo, Roma
2026-04-30
Recruiting
Hoffmann-La Roche
Phase 3
360
Naples, Milan, Rozzano, Florence
2026-04-27
Active, closed
Integrated Clinical-Occupational Management for Workers With Chronic Noncommunicable Diseases
NCT07694609Inflammatory Bowel Diseases (IBD), Crohn Disease, Ulcerative Colitis (UC)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
200
Rome, Naples
2026-04-23
Not yet open
Tinnitus and Treatment With umPEA-LUT
NCT06718452Tinnitus, Neuroinflammation
University of Campania Luigi Vanvitelli
Not applicable
100
Naples
2026-04-20
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Bologna, Milan, Naples, Prato, Rome
2026-04-17
Recruiting
AstraZeneca
Observational
200
Ancona, Bergamo, Foggia, Meldola, Milan, Modena, Naples, Padova
2026-04-16
Recruiting
Novo Nordisk A/S
Phase 3
400
Naples, Modena, Udine, Rome, Milan, San Donato Milanese, Verona
2026-04-13
Recruiting
Incyte Corporation
Phase 3
588
Bologna, Brescia, Candiolo, Foggia, Milan, Naples, Pisa, Roma
2026-04-09
Recruiting
Hoffmann-La Roche
Phase 2
80
Naples, Meldola, Rome, Bergamo, Milan
2026-04-07
Not yet open
University of Naples
Observational
312
Naples
2026-04-01
Not yet open
National Cancer Institute, Naples
Phase 2
156
Naples
2026-04-01
Recruiting
University of Turin, Italy
Not applicable
820
Rozzano, Bologna, Florence, Foggia, Genova, Milan, Modena, Naples
2026-03-30
Recruiting
Bristol-Myers Squibb
Phase 3
850
Naples, Ravenna, Aviano, Orbassano, Rome, Milan, Parma
2026-03-16
Recruiting
National Cancer Institute, Naples
Phase 2
84
Naples
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Naples, Turin, Padova, Milan, Roma
2026-03-13
Recruiting
National Cancer Institute, Naples
Phase 2
80
Naples
2026-03-12
Recruiting
Bristol-Myers Squibb
Phase 3
750
Ferrara (Cona), Aviano, Catania, Candiolo, Genova, Milan, Naples, Novara
2026-03-12
Recruiting
Hoffmann-La Roche
Phase 2
360
Chieti, Naples, Salerno, Roma, Genoa, Milan, Pavia
2026-03-10
Recruiting
Partial Enteral Nutrition to Prevent Weight Loss and Sarcopenia in IBD Patients at Nutritional Risk - SIMBA
NCT07433946Ulcerative Colitis (Disorder), Crohn Disease, Malnutrition or Risk of Malnutrition, IBD
Lionhealth Srl Società Benefit
Not applicable
146
Rozzano, Naples, Pavia, Roma
2026-03-09
Recruiting
Incyte Corporation
Phase 3
700
Ancona, Aviano, Bari, Brescia, Candiolo, Catania, Milan, Naples
2026-03-05
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 4
75
Milan, Naples, Rome
2026-03-04
Recruiting
AstraZeneca
Phase 3
508
Bologna, Milan, Naples, Rozzano, Torino
2026-02-23
Recruiting
National Cancer Institute, Naples
Phase 2
50
Naples
2026-02-23
Not yet open
Fall Prevention in Older Adults in an Italian Cohort
NCT07437690Fall Risk, Fall Prevention, Fall Risk, Accidental Falls
Federico II University
Observational
50
Naples
2026-02-20
Recruiting
Casa di Cura Dott. Pederzoli
Observational
64
Naples, Abano Terme, Udine, Peschiera del Garda
2026-02-17
Recruiting
Creation of Compression Anastomosis Using the GT Metabolic Magnet System
NCT07431723Anastomosis, Functional, Colorectal
GT Metabolic Solutions, Inc.
Not applicable
50
Bergamo, Naples
2026-02-16
Recruiting
Bayer
Phase 4
50
Bergamo, Bologna, Florence, Lecce, Milan, Naples, Padova, Pavia
2026-02-13
Recruiting
Eli Lilly and Company
Phase 3
300
Florence, Messina, Naples, Novara, Padova, Verona
2026-02-05
Recruiting
Federico II University
Observational
8
Naples
2026-02-05
Not yet open
Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial
NCT07314853Neoplasm, Cancer, Hemodynamic (MAP) Stability, Cancer Surgery
National Cancer Institute, Naples
Not applicable
176
Naples
2026-02
Recruiting
Federico II University
Phase 2/3
100
Catanzaro, Latina, Naples
2026-02
Recruiting
Targeting Real World Usage In Stroke Treatment
NCT07474935Saccular and Fusiform Aneurysms, Pseudoaneurysm, Vascular Dissection, Perforation
Phenox GmbH
Observational
5,000
Catania, Milan, Naples
2026-01-29
Recruiting
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
NCT07278726ALND, Sentinel Lymph Node Biopsy (SLNB), Targeted Axillary Dissection (TAD)
European Institute of Oncology
Observational
150
Bologna, Forlì, Milan, Naples, Ortona, Pavia, Pisa, Roma
2026-01-28
Recruiting
IDEAYA Biosciences
Phase 3
520
Naples, Milan, Perugia, Florence, Pisa, Rome
2026-01-25
Recruiting
Health and Happiness Research Limited
Not applicable
29
Naples
2026-01-23
Recruiting
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
NCT07159841Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 2/3
153
Naples, Genoa, Milan, Florence
2026-01-22
Recruiting
CSL Behring
Phase 2
84
Brindisi, Milan, Modena, Monza, Naples, Verona
2026-01-22
Recruiting
Boehringer Ingelheim
Phase 3
400
Bari, Milan, Misterbianco (CT), Naples, Orbassano (TO), Roma, Rozzano (MI), Verona
2026-01-16
Recruiting
Eli Lilly and Company
Phase 3
150
Ancona, Bologna, Cagliari, Florence, Milan, Naples, Novara, Padova
2026-01-12
Recruiting
Janssen Research & Development, LLC
Phase 3
258
Acireale, Cagliari, Florence, Foggia, Genova, Merano, Naples, Sassari
2026-01-08
Recruiting
Insmed Incorporated
Phase 3
344
Bologna, Catania, Milan, Modena, Monza, Naples, Pavia, Roma
2026-01-07
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Naples, Misterbianco, Meldola, Milan, Fano, Aviano, Roma, Brescia
2026-01-06
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Naples, Ravenna, Aviano, Orbassano, Siena, Perugia, Bologna, Milan
2026-01-02
Recruiting
Incyte Corporation
Phase 2
56
Bologna, Brescia, Meldola, Milan, Naples, Padova, Roma
2025-12-29
Recruiting
Norgine
Phase 3
212
Bergamo, Florence, Messina, Milan, Naples, Roma
2025-12-29
Recruiting
AstraZeneca
Phase 3
1,100
Brescia, Catania, Florence, Lecco, Milan, Naples, Parma, Pisa
2025-12-29
Recruiting
argenx
Observational
70
Bergamo, Milan, Naples
2025-12-19
Recruiting
argenx
Phase 2
70
Bergamo, Milan, Naples
2025-12-19
Recruiting
UNICANCER
Phase 3
3,902
Aviano, Caserta, Genova, Naples, Padova, Pisa, Pontedera, Roma
2025-12-18
Recruiting
Ascendis Pharma A/S
Phase 3
186
Florence, Genova, Naples, Trieste
2025-12-12
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Bari, Milan, Naples, Padova, Pisa, Roma, Rome
2025-12-12
Recruiting
BeOne Medicines
Phase 1
86
Milan, Naples, Roma, Rozzano
2025-12-11
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
NCT07144163Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 3
150
Genova, Milan, Rozzano, Modena, Padova, Palermo, Naples, Roma
2025-12-11
Recruiting
AstraZeneca
Phase 2
230
Modena, Naples, Palermo, Pisa, Roma, Varese
2025-12-10
Recruiting
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
NCT07226986PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
DrugsAbiraterone·Enzalutamide
Novartis Pharmaceuticals
Phase 1/2
123
Cona, Milan, Naples
2025-12-05
Recruiting
Janssen Research & Development, LLC
Observational
200
Bari, Brescia, Iesi, Milan, Naples, Palermo, Pavia, Perugia
2025-12-04
Recruiting
Janssen Research & Development, LLC
Phase 3
500
Milan, Naples, Palermo, Pavia, Roma, Rozzano
2025-12-03
Recruiting
Meyer Children's Hospital IRCCS
Observational
150
Bari, Milan, Naples, Roma, Torino, Florence
2025-12-02
Recruiting
Bristol-Myers Squibb
Phase 3
650
Naples, Rome, Milan, Pisa, Brescia, Isernia, Roma
2025-12-02
Not yet open
Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
NCT07267780Ovarian Carcinoma, Cervical Carcinoma, Endometrial Carcinoma, Vulvar Carcinoma
National Cancer Institute, Naples
Observational
130
Naples, Palermo
2025-12
Recruiting
Hoffmann-La Roche
Phase 3
250
Naples, Cona (Ferrara), Rome, Milan, Novara, Palermo
2025-11-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Naples, Rome, Milan, Rozzano, Orbassano, Florence, Castelfranco Veneto, Peschiera del Garda
2025-11-26
Recruiting
Debiopharm International SA
Phase 3
119
Ferrara, Genova, Milan, Naples, Padova, Roma, Torino
2025-11-26
Recruiting
Hoffmann-La Roche
Phase 3
900
Naples, Salerno, Bologna, Cassino, Rome, Genoa, Brescia, Milan
2025-11-24
Recruiting
Bayer
Phase 3
111
Bergamo, Bologna, Genova, Milan, Naples, Padova, Roma, Torino
2025-11-19
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 2
144
Milan, Naples, Padova
2025-11-18
Recruiting
ACADIA Pharmaceuticals Inc.
Phase 3
126
Naples, Roma
2025-11-14
Recruiting
Incyte Corporation
Phase 3
250
Bologna, Brescia, Catania, Milan, Naples, Padua, Roma, Rome
2025-11-13
Active, closed
Hoffmann-La Roche
Phase 2
193
Foggia, Naples, Rome, Milan, Pozzilli
2025-11-13
Active, closed
Boehringer Ingelheim
Phase 2
81
Bergamo, Florence, Naples, Roma, Torino
2025-11-13
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Naples, Modena, Rome, Perugia
2025-11-12
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Ancona, Bergamo, Foggia, Pozzilli, Pavia, Roma, Gallarate, Naples
2025-11-11
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Ravenna, Aviano, Orbassano, Candiolo, Avellino, Milan, Naples, Parma
2025-11-05
Recruiting
University of Campania Luigi Vanvitelli
Observational
482
Naples
2025-11-04
Recruiting
Federico II University
Observational
1,500
Naples
2025-11-04
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Naples, Bologna, Aviano, Rome, Genoa, Bergamo, Milan, Monza
2025-11-03
Recruiting
Takeda
Observational
10
Naples, Pavia
2025-11-03
Recruiting
Philogen S.p.A.
Phase 1
56
Bergamo, Milan, Naples
2025-10-31
Recruiting
GlaxoSmithKline
Phase 2
363
Milan, Naples, Roma
2025-10-30
Recruiting
AstraZeneca
Phase 3
100
Aviano, Florence, Meldola, Milan, Naples, Roma
2025-10-30
By invitation
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
NCT07287163Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure
Praxis Precision Medicines
Phase 3
700
Pozzilli, Bosisio Parini, Milan, Naples, Pavia, Pisa, Ponderano, Roma
2025-10-27
Recruiting
Sanofi
Phase 3
60
Meldola, Milan, Naples, Torino, Vicenza
2025-10-24
Recruiting
Hoffmann-La Roche
Phase 3
600
Statte, Naples, Modena, Pesaro, Aviano, Rome, Milan, Monza MI
2025-10-24
Recruiting
Novo Nordisk A/S
Phase 1
30
Florence, Naples
2025-10-23
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Meldola, Rome, Milan, Rozzano, Pisa, Padova, Naples, Verona
2025-10-23
Recruiting
Eli Lilly and Company
Phase 3
1,630
Bologna, Catania, Lecce, Lucca, Milan, Modena, Naples, Prato
2025-10-22
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Alessandria, Bari, Bologna, Brescia, Catania, Florence, Milan, Naples
2025-10-17
Recruiting
National Cancer Institute, Naples
Phase 2
60
Naples
2025-10-16
Recruiting
Eli Lilly and Company
Phase 3
4,500
Bergamo, Bologna, Florence, Milan, Naples, Padova, Palermo, Roma
2025-10-15
Recruiting
Imbria Pharmaceuticals, Inc.
Phase 2
165
Florence, Massa, Milan, Naples
2025-10-06
Recruiting
AstraZeneca
Phase 1/2
283
Milan, Naples, Roma, Rozzano
2025-10-01
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Bari, Genova, Naples, Pavia
2025-09-30
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Bari, Genoa, Rome, Pisa, Castelfranco Veneto, Milan, Naples, Parma
2025-09-30
Recruiting
National Cancer Institute, Naples
Observational
864
Naples
2025-09-30
Recruiting
Clinical Course Of Disease In Participants With FA-CM
NCT06865482Friedreich Ataxia, Cardiomyopathy
Lexeo Therapeutics
Observational
65
Naples
2025-09-30
Not yet open
LUpus Eritematoso Sistemico NETwork and Registry
NCT07175610Systemic Lupus Erythematous (SLE)
Società Italiana di Allergologia, Asma e Immunologia Clinica
Observational
1,500
Ancona, Bari, Battipaglia, Cagliari, Florence, Mantua, Milan, Naples
2025-09-30
Recruiting
Alfasigma S.p.A.
Phase 3
80
Alessandria, Ancona, Milan, Naples, Rome, Trieste
2025-09-29
Recruiting
Daiichi Sankyo
Phase 2/3
630
Naples, Roma, Rozzano
2025-09-26
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Ancona, Cittadella, Lecco, L’Aquila, Messina, Milan, Naples, Novara
2025-09-22
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
L’Aquila, Cagliari, Rozzano, Baggiovara, Bologna, Chieti, Naples, Roma
2025-09-22
Recruiting
Clinical Investigation on a Polynucleotide-based Device Used to Improve Skin Hydration
NCT07151859Aesthetic Improvement of the Skin, Skin Hydration in Healthy Volunteers, Skin Elasticity, Skin Turgor
Mastelli S.r.l
Not applicable
43
Naples
2025-09-18
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Genova, Milan, Modena, Naples, Brescia
2025-09-17
Recruiting
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Phase 4
50
Meldola, Candiolo, Bologna, Milan, Naples, Roma
2025-09-17
Not yet open
GUIDO CAMANNI
Observational
150
Padova, Assisi, Roma, Salerno, Trieste, Varese, Naples
2025-09-15
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Naples, Bologna, Aviano, Genoa, Pontedera, Prato, Milan, Novara
2025-09-11
Recruiting
Janssen Research & Development, LLC
Phase 3
220
Bergamo, Brescia, Genova, Milan, Naples, Roma, Sanatorio San Luigi, Udine
2025-09-10
Recruiting
Emotional Allodynia Questionnaire (AEQ) in Fibromyalgia (PEARL)
NCT07677631Fibromyalgia, Chronic Pain, Nociplastic Pain
University of Bari
Observational
425
Bari, Bologna, Cagliari, Naples, Verona
2025-09-10
Recruiting
AbbVie
Observational
700
L’Aquila, Milan, Naples, Rome, Genova
2025-09-09
Recruiting
Bristol-Myers Squibb
Phase 2
182
Naples, Monza, Milan, Padova, Bologna
2025-09-09
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Florence, Genova, Milan, Naples, Padua, Perugia, Rome, Rozzano
2025-09-08
Recruiting
Federico II University
Phase 4
80
Caserta, Naples
2025-09-08
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Foggia, Milan, Naples, Padova, Palermo, Roma, Rozzano, Torino
2025-09-02
Recruiting
AbbVie
Phase 2
140
Florence, Rozzano, Naples
2025-09-02
Recruiting
Topical Nifedipine 0.3% Plus Lidocaine 1.5% for Uncomplicated Hemorrhoidal Disease
NCT07295886Hemorrhoid Bleeding, Hemorrhoids Prolapse, Hemorrhoid Pain, Hemorrhoid
DrugsNifedipine·Lidocaine
Cardarelli Hospital
Observational
80
Naples
2025-09-02
Recruiting
National Cancer Institute, Naples
Observational
50
Naples
2025-09-01
Active, closed
Novo Nordisk A/S
Observational
245
Milan, Turin, Livorno, Lucca, Bergamo, Catanzaro, Naples, Perugia
2025-08-28
Recruiting
Monaldi Hospital
Observational
120
Naples
2025-08-23
Recruiting
Sanofi
Phase 3
90
Florence, Genoa, Milan, Naples, Meldola, Novara, Palermo, Trieste
2025-08-18
Recruiting
Novo Nordisk A/S
Phase 4
586
Bari, Catanzaro, Naples, Rome, Milan, Messina, Palermo, Fermo
2025-08-15
Recruiting
Takeda
Phase 3
150
Naples, Rome, Catania, Bologna, Milan, Monza, Novara, Torino
2025-08-14
Recruiting
BioNTech SE
Phase 1/2
1,438
Meldola, Milan, Naples, Roma, Rozzano
2025-08-12
Recruiting
Sanofi
Phase 3
192
Florence, Milan, Naples, Rome, Orbassano, Palermo, Verona
2025-08-12
Recruiting
AstraZeneca
Phase 3
700
Arezzo, Bari, Bergamo, Chieti, Genoa, Milan, Naples, Palermo
2025-08-06
Recruiting
ACADIA Pharmaceuticals Inc.
Phase 2
180
Naples, Salerno, Brescia, Roma
2025-08-06
Recruiting
Pfizer
Phase 3
400
Bologna, Meldola, Naples, Milan
2025-08-05
Recruiting
Intergruppo Melanoma Italiano
Observational
270
Bari, Genova, Milan, Modena, Naples, Padova, Perugia, Roma
2025-08-04
Active, closed
The Brain&Senses Study
NCT06991816Mild Cognitive Impairment, Alzheimer Disease, Parkinson
University of Campania Luigi Vanvitelli
Observational
100
Naples
2025-08-01
Recruiting
Adamas Biotech S.r.l.
Not applicable
64
Naples
2025-07-30
Recruiting
Celgene
Phase 3
400
Bologna, Meldola, Rozzano, Pisa, Alessandria, Naples, Torino
2025-07-28
Recruiting
AbbVie
Phase 3
120
San Giovanni Rotondo, Naples, Rome, Trieste
2025-07-28
Recruiting
Celcuity Inc
Phase 3
1,180
Fano, Genova, Meldola, Milan, Modena, Naples, Parma, Pavia
2025-07-24
Recruiting
ISTITUTO FARMOCHIMICO FITOTERAPICO: EPO SRL
Not applicable
135
Naples
2025-07-24
Recruiting
Pfizer
Phase 3
714
Naples, Misterbianco, Meldola, Pesaro (PU), Orbassano, Rome, Roma, Catania
2025-07-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Bergamo, Milan, Naples, Roma
2025-07-21
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Aviano, Bologna, Meldola, Milan, Naples, Orbassano to, Palermo, Roma
2025-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
586
Naples, Foggia, Roma
2025-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Monserrato, Milan, Naples, Padova, Ravenna, Verona
2025-07-16
Recruiting
Bristol-Myers Squibb
Phase 3
426
Naples, Rome, Milan, Pisa, Brescia, Isernia, Roma
2025-07-16
Recruiting
Hoffmann-La Roche
Observational
700
Lecce, Naples, Modena, Ravenna, Rome, Genoa, Bergamo, Milan
2025-07-15
Not yet open
University of Campania Luigi Vanvitelli
Observational
273
Naples
2025-07-15
Recruiting
AbbVie
Observational
250
Castellana Grotte, Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Naples, Turin
2025-07-14
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Orbassano, Brescia, Milan, Naples, Roma
2025-07-03
Recruiting
Devintec Sagl
Not applicable
208
Genova, Milan, Naples, Padova, Roma, Rozzano (MI), Torino
2025-07-02
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Naples, Rome, Genoa, Brescia, Milan, Palermo, Perugia
2025-07-02
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Ancona, Bologna, Brescia, Florence, Forlì, Lecce, Milan, Naples
2025-07-02
Recruiting
Federico II University
Observational
100
Naples
2025-07-01
Recruiting
MedSIR
Phase 2
200
Ancona, Aviano, Florence, Genova, Milan, Modena, Monza, Naples
2025-06-30
Active, closed
Pfizer
Phase 1/2
74
Naples, Meldola, Aviano, Livorno, Bologna, Roma
2025-06-30
By invitation
MoonLake Immunotherapeutics AG
Phase 3
835
Catania, Chieti, Cona, Florence, Milan, Modena, Naples, Perugia
2025-06-27
Recruiting
AstraZeneca
Phase 2
987
Busto Arsizio, Cuneo, Ferrara, Milan, Monza, Naples, Pavia, Roma
2025-06-27
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Bari, Bergamo, Brescia, Cortona AR, Foggia, Forlì, Milan, Naples
2025-06-25
Active, closed
Incyte Corporation
Phase 3
580
Catania, Cona, Florence, Milan, Naples, Roma, Rozzano, Torino
2025-06-23
Active, closed
Calluna Pharma AS
Phase 2
150
Padova, Roma, Siena, Trieste, Modena, Naples, Rozzano
2025-06-20
Recruiting
University of Padova
Observational
100
Mercogliano, Brescia, Rho, Monza, Naples, Ragusa, Cotignola, Sassari
2025-06-20
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Rozzano, Acquaviva delle Fonti, Bergamo, Cuneo, Livorno, Milan, Naples, Pavia
2025-06-19
Active, closed
Incyte Corporation
Phase 3
159
Catania, Milan, Naples, Padova, Rome
2025-06-17
Active, closed
AbbVie
Phase 3
573
Monserrato, Rozzano, Milan, Naples, Rome, Bologna, Padova, Palermo
2025-06-17
Recruiting
A New Tool for Extubation Readiness in Mechanically Ventilated Patients: Readiness for EXtubation Score
NCT07098611Ventilator Weaning, Respiration, Artificial, Respiratory Failure, Extubation Readiness
Medipol University
Observational
470
Naples
2025-06-15
Recruiting
BioNTech SE
Phase 3
480
Bari, Bologna, Catania, Meldola, Milan, Naples, Roma, Torino
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Ancona, Bologna, Catania, Genova, Messina, Milan, Monza (MB), Naples
2025-06-09
Recruiting
AbbVie
Observational
270
Troina, Pozzilli, Milan, Naples, Turin, Rome, Venice, Ancona
2025-06-04
Recruiting
MediWound Ltd
Phase 3
216
Brindisi, Naples, Genoa, Pisa, Padova, Roma
2025-06-01
Not yet open
Maddalena Casale
Observational
1,000
Naples
2025-06
Recruiting
Merck Sharp & Dohme LLC
Phase 2
160
Milan, Naples, Padova, Roma
2025-05-29
Recruiting
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
NCT06904872Short Bowel Syndrome, Malabsorption Syndromes, Short Gut Syndrome, Post-Op Complication
DrugCrofelemer
Napo Therapeutics, S.p.A.
Phase 2
18
Bologna, Naples, Padova
2025-05-29
Recruiting
Immunovant Sciences GmbH
Phase 3
231
Bergamo, Milan, Naples, Rome
2025-05-27
Recruiting
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
NCT05815927Oligometastatic Squamous Cell Carcinoma of the Head and Neck
DrugPembrolizumab
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
200
Bologna, Cuneo, Florence, Milan, Naples, Ravenna, Rome
2025-05-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Meldola, Milan, Catania, Florence, Naples, Pisa, Roma, Torino
2025-05-22
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Bergamo, Naples, Pavia, Pisa, Roma, Rozzano
2025-05-20
Recruiting
SecuraBio
Phase 3
124
Alessandria, Bergamo, Bologna, Naples, Rome
2025-05-19
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Milan, Rossano, Monza, Naples, Pisa, Roma, Rome
2025-05-06
Recruiting
BioNTech SE
Phase 1/2
594
Candiolo, Milan, Naples, Roma, Verona
2025-05-02
Recruiting
Istituto Superiore di Sanità
Not applicable
128
Naples, Rome
2025-05
Active, closed
Eli Lilly and Company
Phase 3
905
Bologna, Catanzaro, Florence, Milan, Naples, Padova, Roma, Torino
2025-04-25
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Bari, Meldola, Naples, Orbassano, Rome, Florence, Genova, Padova
2025-04-24
Recruiting
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
NCT06921993Pneumonia Childhood, Pneumonia, Lung Ultrasound, Antibiotic Stewardship
Meyer Children's Hospital IRCCS
Not applicable
659
Florence, Bergamo, Bologna, Brescia, Genova, Milan, Naples, Novara
2025-04-24
Recruiting
AbbVie
Phase 2
390
Naples
2025-04-24
Recruiting
BioNTech SE
Phase 1/2
380
Bologna, Genova, Milan, Naples, Roma
2025-04-23
Recruiting
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
NCT06965023ST-elevation Myocardial Infarction (STEMI), Microplastics, Nanoplastics, Pollution Exposure
Azienda Ospedaliera "Sant'Andrea"
Observational
130
Roma, Caserta, Catania, Ferrara, Forlì, Milan, Naples, Turin
2025-04-22
Recruiting
Peritoneal Ultrafiltration in Cardio Renal Syndrome.
NCT03994874Congestive Heart Failure
Iperboreal Pharma Srl
Phase 1/2
84
Chieti, Milan, Naples
2025-04-16
Recruiting
Merck Sharp & Dohme LLC
Phase 2
594
Meldola, Rozzano, Palermo, Alessandria, Milan, Naples, Reggio Emilia
2025-04-11
Recruiting
AstraZeneca
Phase 3
830
Candiolo, Lecco, Lucca, Meldola, Milan, Naples, Peschiera del Garda, Pisa
2025-04-10
Recruiting
BeOne Medicines
Phase 3
250
Bari, Florence, Milan, Naples, Novara, Pavia, Perugia, Roma
2025-04-10
Recruiting
Hoffmann-La Roche
Phase 3
450
Tricase (LE), Caserta, Naples, Bologna, Meldola, Modena, Rome, Bergamo
2025-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Aviano, Milan, Pisa, Bari, Brescia, Naples, Padova, Roma
2025-04-09
Recruiting
Bristol-Myers Squibb
Phase 3
194
Naples, Milan, Rome
2025-04-08
Recruiting
Gilead Sciences
Phase 3
695
Aviano, Candiolo, Lucca, Milan, Naples, Pesaro, Peschiera del Garda, Roma
2025-04-04
Recruiting
National Cancer Institute, Naples
Observational
564
Naples, Milan, Roma
2025-04-03
Active, closed
Racial Disparities in Acute Stroke
NCT06955442Ischemic Stroke
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
4,500
Bologna, Crema, Frosinone, Genova, Lecce, Naples, Pavia, Pozzilli
2025-04-03
Not yet open
University of Campania Luigi Vanvitelli
Phase 2
60
Bari, Naples
2025-04-01
Recruiting
Centro Cardiologico Monzino
Phase 2
102
Pavia, Ancona, Milan, Naples
2025-03-31
Active, closed
Sanofi
Phase 2
204
Genoa, Milan, Rozzano, Naples, Padua, Rome, Turin, Alessandria
2025-03-28
Recruiting
AbbVie
Observational
700
Milan, Naples, Turin, Rome, Bari, Palermo
2025-03-28
Recruiting
Eli Lilly and Company
Phase 3
700
Bari, Catania, Genova, Meldola, Milan, Monza, Naples, Orbassano
2025-03-27
Recruiting
AstraZeneca
Phase 3
600
Catania, Florence, Milan, Monza, Naples, Reggio Emilia, Roma, Rome
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
510
Milan, Naples, Padova, Rome, Rozzano
2025-03-27
Recruiting
Mario Negri Institute for Pharmacological Research
Phase 2/3
246
Brescia, Bergamo, Milan, Naples, Novara, Padova, Palermo, Pergine Valsugana
2025-03-26
Active, closed
Immutep S.A.S.
Phase 3
756
Avellino, Aviano, Candiolo, Milan, Naples, Perugia, Reggio Emilia, Terni
2025-03-21
Recruiting
Daiichi Sankyo
Phase 3
582
Bari, Bologna, Catania, Milan, Monza, Naples, Pisa, Ponderano
2025-03-19
Recruiting
Novel Therapeutic Approach for Human T-cell Malignancies
NCT06600568T-Cell Leukemia/Lymphoma, Adult
Istituto Oncologico Veneto IRCCS
Observational
120
Naples, Padova
2025-03-18
Recruiting
AstraZeneca
Phase 3
990
Cona, Florence, Milan, Montebelluna, Naples, Pavia, Roma, Sassari
2025-03-18
Recruiting
Hoffmann-La Roche
Phase 3
600
Bari, Catanzaro, Naples, Rome, Milan, Monza MI, Pavia, Rho
2025-03-17
Active, closed
Ipsen
Phase 1/2
42
Milan, Naples
2025-03-14
Recruiting
Fondazione Policlinico Universitario Campus Bio-Medico
Not applicable
120
Rome, Roma, Naples
2025-03-13
Active, closed
Celgene
Phase 3
960
Milan, Orbassano, Rome, Padova, Arezzo, Foggia, Naples, Terni
2025-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
60
Naples, Florence
2025-03-13
Recruiting
National Cancer Institute, Naples
Phase 2
130
Caserta, Naples, Avellino, Udine, Tricase, Frattamaggiore, Pozzuoli
2025-03-12
Recruiting
AstraZeneca
Phase 2
80
Bologna, Castelfranco Veneto, Florence, Milan, Naples, Pavia, Pisa, Roma
2025-03-12
Active, closed
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Glioblastoma Multiforme (GBM)
DrugsCobolimab·Dostarlimab
GlaxoSmithKline
Phase 1/2
83
Bologna, Naples
2025-03-06
Recruiting
Swedish Orphan Biovitrum
Phase 3
104
Catanzaro, Florence, Milan, Naples, Parma, Rome, Rozzano, Vicenza
2025-03-06
Recruiting
Hoffmann-La Roche
Phase 2
130
Naples, Meldola, Brescia, Milan, Rozzano
2025-03-05
Recruiting
GlaxoSmithKline
Phase 1/2
305
Milan, Roma, Naples
2025-03-04
Recruiting
AstraZeneca
Phase 3
5,000
Bassano del Grappa, Bologna, Desio, Foggia, Genoa, Modena, Naples, Novara
2025-03-03
Recruiting
AstraZeneca
Phase 3
840
Cagliari, Florence, Milan, Naples, Padova, Rozzano, Torino, Tricase
2025-03-01
Recruiting
Incyte Corporation
Phase 3
600
Bari, Brescia, Catania, Chieti, Florence, L’Aquila, Milan, Naples
2025-02-28
Active, closed
iOnctura
Phase 2
85
Bari, Naples, Padova, Rozzano, Siena
2025-02-27
Recruiting
Takeda
Phase 3
171
Naples, Rome, Catania, Bologna, Milan, Monza, Novara, Torino
2025-02-27
Active, closed
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
NCT06856850ALS (Amyotrophic Lateral Sclerosis), FTD, Neuropathic, Psychiatric Disorders
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
230
Milan, Naples, Sassari, Sesto Fiorentino
2025-02-27
Recruiting
Daiichi Sankyo
Phase 3
726
Catania, Florenze, Genova, Milan, Modena, Naples, Padova, Pisa
2025-02-27
Recruiting
Bristol-Myers Squibb
Phase 3
530
Naples, Milan, Rome, Perugia, Peschiera del Garda, Bologna
2025-02-25
Active, closed
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT05485831Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex
DrugCannabidiol
Jazz Pharmaceuticals
Observational
111
Bologna, Catanzaro, Chieti, Florence, Genova, Messina, Milan, Naples
2025-02-24
Not yet open
Cardarelli Hospital
Observational
36
Naples
2025-02-20
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 2
67
Cagliari, Catania, Florence, Milan, Rozzano, Naples, Roma
2025-02-20
Active, closed
Gilead Sciences
Phase 2
39
Milan, Naples
2025-02-18
Recruiting
Novo Nordisk A/S
Phase 3
510
Orbassano, Verona, Brescia, Catania, Modena, Monza, Naples, Padova
2025-02-17
Recruiting
Dr. Inge Winter
Phase 3
418
Brescia, Cagliari, Naples, Turin
2025-02-11
Active, closed
AbbVie
Phase 3
468
Florence, Milan, Naples, Rome, Latina, Pavia, Perugia, Udine
2025-02-10
Active, closed
Sanofi
Phase 3
216
Milan, Naples, Catania
2025-02-06
Recruiting
LEOPARD Training and Validation Data Collection Study
NCT06675604Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
Assistance Publique - Hôpitaux de Paris
Observational
4,500
Ancona, Bari, Bologna, Genova, Milan, Modena, Naples, Padova
2025-02-04
Recruiting
Airway Therapeutics, Inc.
Phase 2/3
366
Bologna, Genova, Milan, Naples, Padova
2025-02-03
Recruiting
BioNTech SE
Phase 3
621
Avellino, Aviano, Cremona, Lucca, Meldola, Monza, Naples, Peschiera del Garda
2025-02-03
Recruiting
NovoCure GmbH
Phase 3
741
Torino, Bologna, Milan, Naples, Padova, Rozzano, Siena
2025-02-03
Recruiting
Impulse Dynamics
Observational
200
Rome, Naples
2025-02-01
By invitation
Graziella di Grezia
Observational
350
Naples
2025-02-01
Recruiting
AbbVie
Observational
1,200
Rozzano, Milan, Naples, Rome, Ancona, Brescia, Campobasso, Catania
2025-01-31
Recruiting
Università Vita-Salute San Raffaele
Not applicable
400
Catanzaro, Florence, Genova, Milan, Monza, Naples, Padova, Udine
2025-01-30
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Rome, Ancona, Milan, Naples, Padova, Pisa, Reggio Emilia, Roma
2025-01-29
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Bologna, Cagliari, Florence, Milan, Naples, Padova, Palermo, Pavia
2025-01-28
Recruiting
IRCCS San Raffaele
Observational
100
Milan, Naples
2025-01-28
Recruiting
Università Vita-Salute San Raffaele
Observational
500
Milan, Naples
2025-01-27
Recruiting
Fondazione Oncotech
Phase 2
51
Catania, Genova, Naples, Padova, Aviano, Roma
2025-01-27
Recruiting
National Cancer Institute, Naples
Early Phase 1
10
Naples
2025-01-24
Recruiting
IRCCS Policlinico S. Donato
Not applicable
30,000
Milan, Ancona, Genova, Naples, Palermo, Pavia, Pozzilli, Rome
2025-01-22
Recruiting
Incyte Corporation
Phase 3
240
Alessandria, Ancona, Bari, Brescia, Catania, Genova, Milan, Naples
2025-01-21
Not yet open
IRCCS San Raffaele
Observational
50
Bologna, Milan, Naples
2025-01-20
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830Parkinson Disease, Parkinson, Idiopathic Parkinson Disease, Early Parkinson Disease (Early PD)
Neuron23 Inc.
Phase 2
150
Milan, Naples, Padua, Pisa, Rome
2025-01-17
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Bologna, Milan, Naples, Rome
2025-01-13
Recruiting
Janssen Research & Development, LLC
Phase 3
750
Ancona, Brescia, Catania, Milan, Naples, Pavia, Roma, Rozzano
2025-01-09
Active, closed
Daiichi Sankyo
Phase 2
335
Catania, Genova, Meldola, Milan, Naples, Terni
2025-01-06
Recruiting
Takeda
Phase 3
396
Milan, Naples, Roma, Rozzano, San Giovanni Rotondo, Torino
2025-01-02
By invitation
Graziella di Grezia
Observational
350
Naples
2025-01-01
By invitation
Graziella di Grezia
Observational
350
Naples
2025-01-01
Recruiting
Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes
NCT07291609Chronic Coronary Syndrome, Microplastics, Nanoplastics, Coronary Artery Disease
Azienda Ospedaliera "Sant'Andrea"
Observational
120
Caserta, Forlì, Milan, Naples, Roma, Verona
2025-01-01
Recruiting
Santen SAS
Phase 3
234
Ferrara, Naples, Roma
2024-12-30
Active, closed
A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis
NCT06752850Haemophilia A (Moderate or Severe), Hemophilia, Classic, Haemophilia, Hemophilia
DrugEfanesoctocog alfa
Swedish Orphan Biovitrum
Phase 4
37
Milan, Naples, Rozzano
2024-12-19
Recruiting
Sanofi
Phase 2
84
Florence, Naples, Brescia, Monza
2024-12-19
Recruiting
Immunovant Sciences GmbH
Phase 2
240
Bologna, Cagliari, Genova, Milan, Naples, Pisa, Roma, Siena
2024-12-17
Recruiting
Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy
NCT06771193Cervical Cancer, Locally Advanced Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer
MSD Italia S.r.l.
Observational
200
Bologna, Catania, Genova, Milan, Modena, Naples, Aviano, Roma
2024-12-17
Recruiting
CUTISS AG
Phase 3
70
Naples, Padova
2024-12-13
Recruiting
National Cancer Institute, Naples
Observational
16,000
Naples
2024-12-10
Recruiting
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
NCT06689956FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA1 Endometrial Cancer FIGO 2023, Stage IA2 Endometrial Cancer FIGO 2023
Mayo Clinic
Observational
212
Verduno, Monza, Milan, Roma, Udine, Naples
2024-12-04
Recruiting
OSE Immunotherapeutics
Phase 3
363
Meldola, San Filippo, Rozzano, Naples, Orbassano, Legnago, Genova, Lecce
2024-12-03
Active, closed
H. Lundbeck A/S
Phase 3
401
Bologna, Milan, Naples, Pisa, Salerno
2024-12-03
Recruiting
Federico II University
Observational
1,500
Naples
2024-12-01
Recruiting
BeOne Medicines
Phase 1/2
80
Bologna, Milan, Naples, Rozzano, Verona
2024-11-27
Active, closed
AbbVie
Observational
1,314
Milan, Naples, Turin, Rome, Ancona, Bari, Catanzaro, Pavia
2024-11-26
Recruiting
Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
NCT07401615Non Small Cell Lung Cancer, Pulmonary Stereotactic Radiotherapy
Istituto Clinico Humanitas
Observational
150
Bergamo, Bologna, Catania, Milan, Rozzano, Naples, Roma, Venezia
2024-11-25
Active, closed
Genmab
Phase 3
191
Monza, Rozzano, Naples, Aviano, Rome, Orbassano, Bergamo, Candiolo
2024-11-25
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Caserta, Cremona, Naples, Rozzano, San Giovanni Rotondo, Torrette, Udine
2024-11-22
Recruiting
Takeda
Phase 3
30
Genova, Messina, Naples, Rome, Trieste
2024-11-19
Recruiting
A Composite Assay for HER2-positive Early-stage Breast Cancer Management
NCT06762977Breast Cancer Early Stage Breast Cancer (Stage 1-3), HER2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
180
Brindisi, Naples
2024-11-13
Recruiting
argenx
Phase 2
81
Florence, Milan, Modena, Naples, Roma, Rozzano
2024-11-11
Active, closed
GlaxoSmithKline
Phase 2
283
Bergamo, Florence, Milan, Naples, Padova, Pisa, Roma
2024-11-11
Recruiting
Study of IMC-P115C in Advanced PRAME-Positive Cancers
NCT07156136PRAME Positive, Cancer, HLA-A*02:01-positive
Immunocore Ltd
Phase 1
140
Milan, Naples
2024-11-07
Recruiting
CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation
NCT06774365Heart Transplantation, Rejection Heart Transplant, HLA Antigens
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
683
Bari, Bologna, Milan, Naples
2024-11-07
Recruiting
Takeda
Phase 3
24
Naples, Turin (Torino)
2024-11-06
Recruiting
National Cancer Institute, Naples
Observational
80
Naples
2024-11-05
Recruiting
University College Cork
Observational
300
Feltre, Bari, Milan, Naples, Pavia
2024-11-04
Recruiting
argenx
Observational
680
Bergamo, Bologna, Naples, Pisa, Roma
2024-11-04
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
NCT06636383Glycogen Storage Disease Type Ia
Ultragenyx Pharmaceutical Inc
Observational
140
Naples, Genoa
2024-11-04
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
100
Ancona, Bergamo, Bologna, Brescia, Candiolo, Florence, Milan, Naples
2024-11-01
Recruiting
Federico II University
Observational
80
Naples
2024-11-01
Recruiting
Hospital Universitario 12 de Octubre
Not applicable
440
Pozzilli, Acerra, Brescia, Latina, Maddaloni, Monza, Naples, Padova
2024-11-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Meldola, Bologna, Cagliari, Naples
2024-10-30
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Genova, Pavia, Naples, Palermo, Roma
2024-10-29
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
104
Naples, Parma, Pisa, Rome, Turin
2024-10-25
Active, closed
Eli Lilly and Company
Phase 2
45
Milan, Naples, Rome
2024-10-25
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
400
Monserrato, Milan, Naples
2024-10-24
Recruiting
Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NCT06681012Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl
Not applicable
330
Bologna, Milan, Naples, Padova, Pavia, Pisa, Roma
2024-10-22
Recruiting
Pfizer
Phase 3
900
Meldola, Rome, Rozzano, Cremona, Milan, Naples, Terni, Trento
2024-10-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Catanzaro, Ravenna, Rome, Milan, Naples, Padova, Verona
2024-10-21
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
617
Alessandria, Bergamo, Bologna, Catania, Florence, Milan, Monza, Naples
2024-10-14
Recruiting
Boehringer Ingelheim
Phase 2
588
Ancona, Aviano (PN), Meldola (FC), Milan, Naples, Rome
2024-10-11
Active, closed
Incyte Corporation
Phase 3
349
Catania, Chieti, L’Aquila, Milan, Naples, Perugia, Pisa, Rome
2024-10-10
Recruiting
National Cancer Institute, Naples
Observational
103
Naples
2024-10-08
By invitation
UCB Biopharma SRL
Phase 3
12
Bologna, Milan, Naples
2024-10-08
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Bari, Ravenna, Monza, Milan, Naples, Rome, Peschiera del Garda, Bergamo
2024-10-07
Recruiting
AstraZeneca
Phase 3
744
Bari, Milan, Misterbianco, Monza, Naples, Orbassano, Padova, Parma
2024-10-04
Not yet open
NBI for Early Diagnosis of OPMD/OSCC
NCT06438939Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorder
Cardarelli Hospital
Not applicable
480
Naples
2024-09-30
Recruiting
GlaxoSmithKline
Phase 1
845
Milan, Naples, Roma, Verona
2024-09-30
Active, closed
Merus B.V.
Phase 3
699
Ancona, Brescia, Cagliari, Meldola, Milan, Naples, Rome, Rozzano
2024-09-25
Active, closed
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
NCT06481891Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
DrugSotagliflozin
Lexicon Pharmaceuticals
Phase 3
500
Arezzo, Brescia, Naples
2024-09-24
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Ferrara, Milan, Naples, Roma
2024-09-19
Recruiting
INOCA-NA a Local Prospective Registry
NCT06588244Ischemia, Myocardial, Non-Obstructive Coronary Atherosclerosis, Microcirculatory Status, Coronary Microvascular Dysfunction (CMD)
Federico II University
Observational
250
Naples
2024-09-19
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Cuneo, Ferrara, Milan, Naples, Novara, Pisa, Rome, Taormina
2024-09-18
Active, closed
argenx
Phase 3
141
Bergamo, Bologna, Milan, Naples, Roma
2024-09-18
Active, closed
GlaxoSmithKline
Phase 2
153
Genova, Milan, Naples, Roma, Sassari
2024-09-17
Active, closed
Hoffmann-La Roche
Phase 3
400
Matera, Naples, Rome, Pavia, Rho
2024-09-17
Recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
NCT06586515Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer
DrugsLeucovorin·Irinotecan·Cetuximab·Adrucil
Eli Lilly and Company
Phase 1
630
Naples, Roma, Verona
2024-09-12
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
DrugsABP 234·Pembrolizumab
Amgen
Phase 3
163
Cona, Cuneo, Florence, Lucca, Monserrato, Naples, Peschiera del Garda, Ravenna
2024-09-12
Recruiting
GlaxoSmithKline
Phase 3
440
Ancona, Milan, Modena, Naples, Padova, Palermo, Pavia, Pisa
2024-09-11
Recruiting
Laura Deborah Locati
Not applicable
60
Naples, Pavia, Sassari
2024-09-09
Active, closed
Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia
NCT06832371Homozygous Familial Hypercholesterolemia (HoFH), Major Adverse Cardiovascular Events (MACE), Dyslipidemia
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
73
Catanzaro, Caserta, Naples, Bologna, Ferrara, Modena, Genova, Catania
2024-09-09
Recruiting
Prevention ICONA Dedicated Ensemble
NCT07186244PrEP, PrEP Adherence Monitoring, HIV, HIV -1 Infection
Fondazione ICONA
Observational
5,000
Chieti, Pescara, Bari, Foggia, Potenza, Caserta, Naples, Bologna
2024-09-09
Active, closed
Amgen
Phase 3
315
Cona, Cremona, Milan, Naples, Ravenna, Sondrio, Terni
2024-09-09
Recruiting
Valerio Nardone
Observational
1,000
Barletta, Campobasso, Lecce, Naples, Potenza, Roma
2024-09-06
By invitation
Federico II University
Not applicable
150
Naples
2024-09-06
Recruiting
SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective
NCT06373601Coronary Artery Disease, Stenosis Coronary, Coronary Artery Lesion, Percutaneous Coronary Intervention
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
Not applicable
140
Mercogliano, Bergamo, Brescia, Ferrara, Milan, Rozzano, Naples, Orbassano
2024-09-05
Recruiting
Clinical-ultrasonographic Assessment of Pulmonary Emphysema
NCT06533371Emphysema, Pulmonary Emphysema
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
1,628
Acquaviva delle Fonti, Naples, Rome, Trento
2024-09-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Bologna, Naples, Pavia, Roma
2024-09-03
By invitation
Giovanni Di Perri
Observational
200
Genova, Milan, Torino, Bari, Catania, Naples, Padova, Roma
2024-09-02
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
200
Bologna, Naples
2024-09-01
Recruiting
Dr. Inge Winter
Phase 3
418
Brescia, Cagliari, Naples, Turin
2024-08-31
Active, closed
IRCCS SYNLAB SDN
Observational
80,000
Naples
2024-08-30
Recruiting
Multidimensional Omics Analysis in Malignant Pleural Mesothelioma
NCT07561190Malignant Pleural Mesothelioma (MPM)
Azienda USL Reggio Emilia - IRCCS
Observational
300
Catania, Naples, Reggio Emilia, Roma
2024-08-30
Active, closed
Celgene
Phase 2
95
Rome, Rozzano, Bologna, Naples
2024-08-30
Active, closed
Microbiotica Ltd
Phase 1
41
Milan, Naples, Rozzano
2024-08-28
Active, closed
AstraZeneca
Phase 2
194
Genoa, Meldola, Milan, Naples, Orbassano, Perugia, Rozzano, Udine
2024-08-27
Recruiting
AstraZeneca
Phase 3
620
Florence, Milan, Naples, Padova, Roma, Rozzano, Tricase
2024-08-12
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
102
Aviano, Meldola, Milan, Naples, Perugia, Roma, Rozzano
2024-08-07
Recruiting
AstraZeneca
Phase 3
788
Bergamo, Bologna, Milan, Modena, Naples, Padova, Reggio Emilia, Rome
2024-08-01
Active, closed
GlaxoSmithKline
Phase 3
10,212
Negrar, Alessandria, Bari, Belluno, Ferrara, Naples, Palermo, Pessione - Chieri to
2024-08-01
Recruiting
Continuous Glucose Monitoring in HIE
NCT06563687Hypoxic Ischemic Encephalopathy of Newborn, Hyperglycemia, Hypoglycemia
University of Campania Luigi Vanvitelli
Not applicable
70
Avellino, Naples
2024-08-01
Recruiting
Fondazione Melanoma Onlus
Not applicable
20
Naples
2024-08-01
Recruiting
Dr. Inge Winter
Phase 4
418
Brescia, Cagliari, Naples, Turin
2024-08-01
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-07-30
Recruiting
Marco Emilio Bianchi
Observational
70
Naples, Milan
2024-07-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Bologna, Milan, Monza, Rozzano, Turin, Brescia, Catania, Naples
2024-07-24
Recruiting
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
NCT06427941Metastatic Hepatocellular Carcinoma, Local Advanced Hepatocellular Carcinoma, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Extragonadal Yolk Sac Tumors
DrugsTislelizumab·Bevacizumab
BeOne Medicines
Phase 1/2
630
Naples, Padova, Roma, Rozzano
2024-07-23
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Monserrato, Candiolo, Genova, Milan, Naples, Padova, Pisa, Roma
2024-07-19
Recruiting
Digital diagnoSis of Cardiac sOUNd in peDiatric Patients [DI-SOUND Study]
NCT07542509Cardiac Disease, Auscultation of Heart, Machine Learning
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,000
Bologna, Milan, Roma, Naples
2024-07-18
Recruiting
Vor Biopharma
Phase 3
180
San Giovanni Rotondo, Naples, Cefalù, Pavia, Rome
2024-07-17
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
38
Milan, Naples
2024-07-17
Recruiting
Amgen
Phase 3
450
Brescia, Castellana Grotte, Florence, Foggia, Genova, Meldola FC, Milan, Naples
2024-07-17
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Naples, Ferrara, Piacenza, Florence, Livorno, Bergamo, Milan, Pesaro
2024-07-16
Recruiting
Philogen S.p.A.
Phase 2
162
Naples
2024-07-12
Active, closed
Fidia Farmaceutici s.p.a.
Not applicable
72
Milan, Naples, Roma, Torino
2024-07-12
Active, closed
Celldex Therapeutics
Phase 3
963
Ancona, Mantua, Milan, Naples, Torino, Verona
2024-07-11
Recruiting
Polyspecific Antibodies in Lymphoproliferative T-cell Disorders
NCT06495723Peripheral T Cells Lymphoma (PTCL)
Xenothera SAS
Phase 1/2
54
Naples, Bologna, Milan
2024-07-09
Active, closed
Amgen
Phase 3
89
Naples, Pisa
2024-07-05
Recruiting
GlaxoSmithKline
Phase 1
675
Aviano PN, Milan, Naples, Roma
2024-07-02
Recruiting
AAVantgarde Bio Srl
Phase 1/2
15
Naples
2024-07-02
Active, closed
AstraZeneca
Phase 3
339
Brescia, Cona, Florence, Milan, Naples, Reggio Emilia, Roma, Rome
2024-06-29
Recruiting
Boehringer Ingelheim
Phase 1/2
768
Ancona, Candiolo (TO), Meldola (FC), Milan, Misterbianco (CT), Naples, Rozzano
2024-06-28
Active, closed
AbbVie
Phase 3
1,400
Cona, Florence, Rozzano, Naples, Rome, Catania, Milan
2024-06-27
Active, closed
Merus B.V.
Phase 3
621
Brescia, Cuneo, Milan, Naples, Roma, Rozzano
2024-06-25
Recruiting
Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial Toxicity
NCT06887244Patient Satisfaction and Efficacy of Bowel-preparation, Colon Cancer Prevention
National Cancer Institute, Naples
Not applicable
534
Naples
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Naples, Misterbianco, Meldola (FC), Aviano, Rome, Brescia, Milan, Monza
2024-06-24
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Bologna, Florence, Milan, Rozzano, Naples, Padova, Rome, Torino
2024-06-19
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bergamo, Foggia, Genova, Naples, Pavia, Roma, Rozzano
2024-06-17
Active, closed
UCB Biopharma SRL
Phase 2/3
14
Bologna, Milan, Naples
2024-06-14
Recruiting
Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
NCT06749600Primary Ovarian Leiomyosarcoma
Azienda USL Reggio Emilia - IRCCS
Observational
30
Modena, Parma, Reggio Emilia, Avellino, Catania, Milan, Monza, Naples
2024-06-14
Recruiting
National Cancer Institute, Naples
Phase 3
500
Naples
2024-06-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Naples, Rome, Milan, Monza, Rozzano, Brescia, Genova, Novara
2024-06-10
Active, closed
Exelixis
Phase 2/3
600
Candiolo, Brescia, Catania, Milan, Naples, Rome, Rozzano, Verona
2024-06-07
Recruiting
Immunocore Ltd
Phase 3
680
Bari, Bergamo, Meldola, Milan, Modena, Naples, Padova, Perugia
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Bari, Monserrato, Rome, Milan, Rozzano, Naples, Turin, Pontedera
2024-06-05
Active, closed
Kumquat Biosciences Inc.
Phase 1
92
Rome, Naples
2024-06-03
Recruiting
Hedera Dx SA
Observational
1,000
Naples
2024-06-01
Active, closed
University of Campania Luigi Vanvitelli
Observational
150
Naples
2024-06-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Naples, Ravenna, Aviano, Rome, Milan, Livorno, Padova
2024-05-24
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
28
Alessandria, Aviano, Bologna, Brescia, Milan, Naples, Novara, Palermo
2024-05-23
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Alessandria, Lecco, Milan, Monza, Naples, Pavia, Modena, Roma
2024-05-20
Active, closed
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms
DrugsTucatinib·Disitamab Vedotin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
54
Naples, Milan, Misterbianco (CT), Verona
2024-05-20
Recruiting
NMD Pharma A/S
Phase 2
84
Bergamo, Bologna, Genova, Milan, Naples, Pisa, Roma
2024-05-16
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Milan, Naples, Padova, Pavia, Roma
2024-05-15
Active, closed
Boehringer Ingelheim
Phase 2
190
Florence, Milan, Naples, Roma, Rozzano, Torrette Di Ancona
2024-05-15
Active, closed
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
NCT06295731Head and Neck Squamous Cell Carcinoma (HNSCC)
DrugsKeytruda·Pembrolizumab
Inhibrx Biosciences, Inc
Phase 2/3
410
Naples, Milan, Pavia
2024-05-14
Recruiting
Centro di Riferimento Oncologico - Aviano
Observational
1,000
Aviano, Caserta, Naples, Trieste
2024-05-13
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-05-13
By invitation
Federico II University
Not applicable
20
Naples
2024-05-03
Recruiting
Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
NCT06905145Head and Neck Squamous Cell Carcinoma, Locally Advanced Stage
National Cancer Institute, Naples
Observational
128
Naples
2024-05-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
450
Naples, Rome, Milan, Pisa
2024-05-03
Recruiting
Francesco De Cobelli
Phase 2
33
Bergamo, Milan, Naples, Pisa
2024-04-30
Recruiting
Eli Lilly and Company
Phase 3
510
Florence, Milan, Naples, Padova, Pisa, Rome, Vimercate
2024-04-29
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Bologna, Milan, Naples, Pontedera Pisa, Rho, Roma, Rozzano, San Giovanni Rotondo
2024-04-17
Active, closed
Bristol-Myers Squibb
Phase 3
44
Florence, Genova, Naples
2024-04-17
Recruiting
Daiichi Sankyo
Phase 1/2
680
Candiolo, Milan, Naples, Rome, Rozzano
2024-04-10
Active, closed
Novartis Pharmaceuticals
Phase 2
23
Milan, Naples
2024-04-04
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
375
Torrette, Naples, Bologna, Venezia, Pavia, Milan, Rozzano, Catania
2024-04-03
Active, closed
AstraZeneca
Phase 3
2,554
Bologna, Catanzaro, Chiavari, Desio, Milan, Naples, Parma, Rozzano
2024-03-29
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Rome, Genoa, Milan, Naples
2024-03-28
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
NCT06253871HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer, HER2 + Breast Cancer
Iambic Therapeutics, Inc
Phase 1
383
Florence, Milan, Naples
2024-03-25
Recruiting
GlaxoSmithKline
Phase 3
864
Bolzano, Bologna, Milan, Naples, Pavia, Prato, Roma, Rozzano MI
2024-03-21
Active, closed
GlaxoSmithKline
Phase 4
336
Genova, Monserrato CA, Naples, Pieve Di Soligo TV, Roma, Rozzano, Verona
2024-03-20
Recruiting
Verastem, Inc.
Phase 3
270
Aviano, Brescia, Catania, Milan, Naples, Padova, Roma, Rome
2024-03-18
Recruiting
Cooling in Mild Encephalopathy
NCT05889507Neonatal Encephalopathy, Newborn Asphyxia
Imperial College London
Phase 3
426
Naples
2024-03-15
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Bergamo, Foggia, Milan, Modena, Naples, Novara, Palermo, Roma
2024-03-13
Recruiting
Elixir Medical Corporation
Observational
5,000
Milan, Naples, Rome
2024-03-10
Recruiting
University Hospital of Ferrara
Not applicable
236
Ferrara, Naples
2024-03-08
Recruiting
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT06217822Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression
Bayer
Phase 1
198
Milan, Naples
2024-03-07
Active, closed
AstraZeneca
Phase 3
594
Florence, Milan, Naples, Padova, Pisa, Vicenza
2024-03-04
Active, closed
Sanofi
Phase 3
464
Turin, Chieti, Modena, Naples, Perugia
2024-02-29
Recruiting
medac GmbH
Phase 3
277
Arezzo, Ferrara, Florence, Naples, Parma, Pisa
2024-02-27
Recruiting
Daiichi Sankyo
Phase 2/3
860
Aviano, Bologna, Catania, Florence, Milan, Monza, Naples, Roma
2024-02-27
Active, closed
Fundación EPIC
Observational
501
Naples, Palermo
2024-02-26
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
740
Bergamo, Genova, Naples, Verona
2024-02-26
Active, closed
Dianthus Therapeutics
Phase 2
65
Milan, Naples, Pisa, Rome
2024-02-23
Active, closed
AstraZeneca
Phase 2
142
Bari, Bologna, Milan, Naples, Palermo, Pavia, Peschiera del Garda
2024-02-22
Recruiting
AstraZeneca
Phase 3
5,250
Ancona, Florence, Genoa, Mestre, Milan, Naples, Pavia, Perugia
2024-02-21
Active, closed
Gemelli Molise Hospital
Observational
372
Taranto, Naples, Milan, Campobasso
2024-02-20
Active, closed
Tourmaline Bio, Inc., a Novartis Company
Phase 2
79
Naples, Pisa
2024-02-19
Recruiting
Amicus Therapeutics
Observational
500
Bari, Naples, Torino, Udine
2024-02-16
Active, closed
Boehringer Ingelheim
Phase 3
428
Bari, Candiolo (TO), Catania, Naples, Parma, Roma, Varese
2024-02-09
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Bologna, Candiolo, Catania, Lecce, Meldola, Messina, Milan, Naples
2024-02-05
Recruiting
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
NCT05966467Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD
Alexion Pharmaceuticals, Inc.
Observational
122
Naples
2024-02-01
Recruiting
The PRO-FUTURE Project
NCT06382233Ureteropelvic Junction Obstruction, Chronic Kidney Diseases
University of Campania Luigi Vanvitelli
Observational
85
Naples, Milan, Modena
2024-01-30
Active, closed
BicycleTx Limited
Phase 2
375
Aviano, Genova, Naples
2024-01-24
Active, closed
DualityBio Inc.
Phase 3
541
Bergamo, Brescia, Catania, Catanzaro, Milan, Pavia, Verona, Naples
2024-01-18
Recruiting
Azienda Ospedaliero-Universitaria di Modena
Not applicable
30
Roma, Trieste, Modena, Naples
2024-01-17
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,181
Bologna, Ferrara, Florence, Forlì, Messina, Milan, Naples, Padova
2024-01-11
Active, closed
AbbVie
Phase 2/3
89
Rozzano, Milan, Naples, Rome, Bologna, Palermo, Roma
2024-01-11
Recruiting
Translumina Therapeutics Pvt Ltd.
Observational
2,000
Campobasso, Mercogliano AV, Naples, Padova, Pescara, Roma
2024-01-10
Recruiting
Daiichi Sankyo
Phase 3
50
Milan, Naples
2024-01-05
Active, closed
Novartis Pharmaceuticals
Phase 2
49
Genova, Milan, Roma, Naples
2024-01-03
By invitation
Sanofi
Phase 3
90
Milan, Padua, Rome, Naples, Pavia
2024-01-03
Recruiting
Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
NCT06356727Heart Failure, Left Ventricular Dysfunction, Idiopathic Dilated Cardiomyopathy
Azienda Ospedaliera Universitaria Integrata Verona
Not applicable
190
Ferrara, Genova, Milan, Naples, Roma, Rome, Torino, Verona
2024-01-03
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
2,800
Naples, Palermo, Perugia, Reggio Emilia
2024-01-01
Recruiting
Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients
NCT06769308Sedation Complication, Mechanical Ventilation Complication
Università degli Studi di Ferrara
Not applicable
174
Ferrara, Naples
2024-01-01
Recruiting
Daiichi Sankyo
Phase 3
250
Bari, Bologna, Genova, Milan, Misterbianco, Naples, Padova, Prato
2023-12-30
Recruiting
Federico II University
Not applicable
100
Naples, Novara, Pisa, Roma
2023-12-29
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
DrugSurovatamig
AstraZeneca
Phase 1/2
255
Bergamo, Bologna, Monza, Naples, Roma
2023-12-29
Active, closed
Sanofi
Phase 3
943
Augusta, Cona, Florence, Genoa, Milan, Naples, Cefalù, Rome
2023-12-27
Recruiting
Eli Lilly and Company
Phase 3
1,264
Bari, Bologna, Catania, Milan, Naples, Padova, Roma, Rome
2023-12-21
Active, closed
Bristol-Myers Squibb
Phase 3
190
Aviano, Milan, Monza, Naples, Rome
2023-12-21
Active, closed
Bioprojet
Phase 2
62
Bologna, Bosisio Parini, Cagliari, Calambrone, Foggia, Messina, Naples, Pavia
2023-12-20
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Naples, Rome, Brescia, Milan, Rozzano, Turin, Monserrato, Pisa
2023-12-20
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Ancona, Candiolo, Meldola, Milan, Naples, Parma, Pisa, Rozzano
2023-12-20
Recruiting
Janssen-Cilag Ltd.
Observational
900
Bologna, Bolzano, Brindisi, Florence, Lecce, Milan, Naples, Palermo
2023-12-18
Recruiting
AstraZeneca
Phase 3
1,145
Aviano, Florence, Milan, Modena, Naples, Padova, Pavia, Rozzano
2023-12-14
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
54
Naples, Palermo, Bologna, Milan, Padova, Roma, Rozzano
2023-12-13
Active, closed
Sanofi
Phase 3
1,655
Cona, Florence, Genoa, Milan, Monza, Naples, Rome, Orbassano
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Meldola, Monza, Turin, Milan, Modena, Naples, Novara, Pavia
2023-12-13
Recruiting
AbbVie
Phase 3
110
Genoa, Naples, Rome, Messina
2023-12-11
Active, closed
Sanofi
Phase 2
197
Torette, Florence, Milan, Naples, Rome, Novara, Varese, Verona
2023-12-11
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Brindisi, Avellino, Naples, Bologna, Meldola, Parma, Aviano (PN), Udine
2023-12-11
Recruiting
IRCCS SYNLAB SDN
Observational
50
Naples
2023-12-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Bari, Aviano, Udine, Milan, Naples, Perugia, Catania, Cuneo
2023-12-06
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
257
Castellana Grotte, Catania, Florence, Genova, Milan, Modena, Naples, Pisa
2023-12-05
Recruiting
Multicenter Evaluation of Patients Using LATITUDE Monitoring System
NCT06311149Cardiovascular Diseases, Arrhythmias, Cardiac, Heart Failure, Sudden Cardiac Death
University Hospital of Ferrara
Observational
20,000
Ferrara, Naples, Roma
2023-12-01
Rows per page Showing 1–500 of 983
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/naples

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 983 of those studies with a site in Naples.

How many clinical trials are recruiting in Naples?

509 of the 983 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 40 have not yet opened recruitment, 417 are active but closed to new participants, and 17 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Naples), 983 studies
PhaseStudiesRecruitingShare
Phase 342018142.7%
Observational20514220.9%
Phase 21486115.1%
Not applicable70417.1%
Phase 1/247294.8%
Phase 2/339224%
Phase 134183.5%
Phase 419141.9%
Early Phase 1110.1%

Most active sponsors

Lead sponsors with the most studies (Naples)
Lead sponsorStudiesRecruiting
AstraZeneca7929
Hoffmann-La Roche4814
Merck Sharp & Dohme LLC4018
Bristol-Myers Squibb3718
National Cancer Institute, Naples3629
Federico II University3226
AbbVie2711
Eli Lilly and Company2211
Janssen Research & Development, LLC2011
Novartis Pharmaceuticals208
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.